Table 3.
Immunomulatory therapy before starting the infliximab therapy in patients with HLA-B27 ocular inflammation
|
| |
| Immunomodulatory therapy | Number (%) |
| Methotrexate | 10 (41.6%) |
| Mycophenolate Mofetil | 5 (20.8%) |
| Humira | 5 (20.8%) |
| Cyclosporine | 2 (8.33%) |
| Chlorambucil | 1 (4.16%) |
| Daclizumab | 1 (4.16%) |
| Etanercept | 1 (4.16%) |
| Azathioprine | 1 (4.16%) |
| Celecoxib | 1 (4.16%) |
| None | 4 (16.6%) |